Perioperative management of cranial diabetes insipidus in a patient requiring a tracheostomy.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
09 Apr 2021
Historique:
entrez: 10 4 2021
pubmed: 11 4 2021
medline: 15 5 2021
Statut: epublish

Résumé

Cranial diabetes insipidus (DI), which can cause life-threatening dehydration, is treated with desmopressin, often intranasally. This is challenging in patients whose nasal airflow is altered, such as those requiring tracheostomy. We report the case of a patient, taking intranasal desmopressin for cranial DI, who underwent partial glossectomy, free-flap reconstruction and tracheostomy. Postoperatively, she could not administer nasal desmopressin due to reduced nasal airflow. She developed uncontrollable thirst, polyuria and hypernatraemia. Symptoms were relieved by switching to an enteric formulation. A literature review showed no cases of patients with DI encountering difficulties following tracheostomy. The Royal Society of Endocrinology recommends perioperative planning for such patients, but gives no specific guidance on medication delivery in the context of altered airway anatomy. Careful perioperative planning is required for head and neck patients with DI, particularly for those undergoing airway alteration that may necessitate a change in the mode of delivery of critical medications.

Identifiants

pubmed: 33837022
pii: 14/4/e239261
doi: 10.1136/bcr-2020-239261
pmc: PMC8043018
pii:
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Endocr Connect. 2018 Jul;7(7):G8-G11
pubmed: 29930026
BMJ. 2019 Feb 28;364:l321
pubmed: 30819684
Clin Endocrinol (Oxf). 2019 Jan;90(1):23-30
pubmed: 30269342
Acta Otolaryngol. 1994 Jul;114(4):443-6
pubmed: 7976317
Brain Res Bull. 2018 Oct;143:155-170
pubmed: 30449731
N Engl J Med. 2000 Oct 5;343(14):998-1007
pubmed: 11018166
J Clin Endocrinol Metab. 2013 Oct;98(10):3958-67
pubmed: 23884783
Curr Drug Saf. 2007 Sep;2(3):232-8
pubmed: 18690973

Auteurs

Mairead Kelly (M)

Department of Otolaryngology and Head and Neck Surgery, Guy's and Saint Thomas' NHS Foundation Trust, London, UK maireadchristinekelly@gmail.com.

Misha Verkerk (M)

Department of Otolaryngology and Head and Neck Surgery, Guy's and Saint Thomas' NHS Foundation Trust, London, UK.

Patrick Harrison (P)

Department of Otolaryngology and Head and Neck Surgery, Guy's and Saint Thomas' NHS Foundation Trust, London, UK.

Richard Oakley (R)

Department of Otolaryngology and Head and Neck Surgery, Guy's and Saint Thomas' NHS Foundation Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH